Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience

Nucleic Acid Therapeutics - United States
doi 10.1089/nat.2018.0753

Related search